NEW YORK (GenomeWeb) – Affymetrix said after the close of the market on Wednesday that total revenues moved up a fraction of 1 percent year over year in the fourth quarter.

For the three months ended Dec. 31, 2014 total revenues were $93.5 million compared to $92.6 million a year ago and above the consensus Wall Street estimate of $91.8 million. The revenues were slightly higher than those reported last month in Affymetrix's pre-announcement of revenues. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.